Kelderman Kim 4

What Happened
Kim Kelderman, CEO of Bio‑Techne Corp (TECH), exercised or converted derivative awards for 11,344 shares on 2026-04-22. The filing shows 11,344 shares acquired at $0.00 per share (reporting code M). To cover tax obligations, 1,363 shares were surrendered/withheld (reporting code F) at an indicated value of $58.58 per share, totaling about $79,845. Net shares received from the transaction = 11,344 − 1,363 = 9,981 shares.

Key Details

• Transaction date: 2026-04-22; Form 4 filed 2026-04-24 (timely filing).
• Exercise/Conversion (M): 11,344 shares acquired at $0.00 per share.
• Tax withholding/payment (F): 1,363 shares disposed/withheld at $58.58 per share = $79,845.
• Net shares retained after withholding: 9,981 (11,344 − 1,363).
• Footnote F indicates shares were used to satisfy tax obligations; other listed footnotes in the filing relate to vesting schedules of outstanding awards.
• No late filing flagged in this report.

Context

• This was an exercise/conversion of a derivative award reported at $0.00 per share; the simultaneous withholding/sale of shares to satisfy taxes (code F) is a common administrative step and does not necessarily signal a broader buying or selling intent.
• For retail investors, exercises with partial withholding are routine—what matters more is whether executives are buying shares with cash or selling shares for cash beyond tax withholding. In this filing, the only sale reported was the withholding to meet taxes.